T. Rasmuson

1.2k total citations
21 papers, 610 citations indexed

About

T. Rasmuson is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, T. Rasmuson has authored 21 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in T. Rasmuson's work include Renal cell carcinoma treatment (5 papers), Lymphoma Diagnosis and Treatment (3 papers) and Renal and related cancers (2 papers). T. Rasmuson is often cited by papers focused on Renal cell carcinoma treatment (5 papers), Lymphoma Diagnosis and Treatment (3 papers) and Renal and related cancers (2 papers). T. Rasmuson collaborates with scholars based in Sweden, United States and Netherlands. T. Rasmuson's co-authors include Börje Ljungberg, Kjell Grankvist, Jan Jacobsen, Anders Bergh, Göran Landberg, Albert E. Pye, Ingrid Faye, Hans G. Boman, Glenn R. Björk and Torgny Stigbrand and has published in prestigious journals such as Infection and Immunity, British Journal of Cancer and European Urology.

In The Last Decade

T. Rasmuson

21 papers receiving 570 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Rasmuson Sweden 13 311 229 157 127 115 21 610
Bence Kiss Hungary 13 333 1.1× 66 0.3× 27 0.2× 53 0.4× 180 1.6× 32 610
Ilona Moßbrugger Germany 8 242 0.8× 148 0.6× 105 0.7× 82 0.6× 50 0.4× 10 557
Satoshi Shiojima Japan 15 435 1.4× 62 0.3× 40 0.3× 94 0.7× 120 1.0× 21 789
Tetsuhiro Tsuruma Japan 18 361 1.2× 54 0.2× 405 2.6× 65 0.5× 366 3.2× 58 870
Deric D. Schoof United States 17 221 0.7× 45 0.2× 406 2.6× 41 0.3× 618 5.4× 34 866
H Okazaki Japan 9 261 0.8× 35 0.2× 43 0.3× 31 0.2× 57 0.5× 14 537
Laurie Burdett United States 17 448 1.4× 87 0.4× 135 0.9× 128 1.0× 106 0.9× 29 840
Melanie Grusdat Germany 8 193 0.6× 64 0.3× 190 1.2× 91 0.7× 492 4.3× 10 745
Yoko Ino Japan 13 282 0.9× 52 0.2× 87 0.6× 97 0.8× 44 0.4× 37 510
Anna Aspesi Italy 19 743 2.4× 109 0.5× 177 1.1× 85 0.7× 111 1.0× 36 1.1k

Countries citing papers authored by T. Rasmuson

Since Specialization
Citations

This map shows the geographic impact of T. Rasmuson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Rasmuson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Rasmuson more than expected).

Fields of papers citing papers by T. Rasmuson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Rasmuson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Rasmuson. The network helps show where T. Rasmuson may publish in the future.

Co-authorship network of co-authors of T. Rasmuson

This figure shows the co-authorship network connecting the top 25 collaborators of T. Rasmuson. A scholar is included among the top collaborators of T. Rasmuson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Rasmuson. T. Rasmuson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jacobsen, Jan, Kjell Grankvist, T. Rasmuson, et al.. (2004). Expression of vascular endothelial growth factor protein in human renal cell carcinoma. British Journal of Urology. 93(3). 297–302. 146 indexed citations
2.
Andersson, Roger, et al.. (2004). Improved method for analysis of cysteinyldopa in human serum. Scandinavian Journal of Clinical and Laboratory Investigation. 64(6). 559–564. 2 indexed citations
3.
Jacobsen, Jan, Kjell Grankvist, T. Rasmuson, & Börje Ljungberg. (2002). Prognostic importance of serum vascular endothelial growth factor in relation to platelet and leukocyte counts in human renal cell carcinoma. European Journal of Cancer Prevention. 11(3). 245–252. 22 indexed citations
4.
Hotakainen, Kristina, Börje Ljungberg, Annukka Paju, et al.. (2002). The free β-subunit of human chorionic gonadotropin as a prognostic factor in renal cell carcinoma. British Journal of Cancer. 86(2). 185–189. 44 indexed citations
5.
Boshuizen, Hendriek C., H. Bas Bueno‐de‐Mesquita, Antonio Agudo, et al.. (2002). Adjustment for smoking in lung cancer analyses in the EPIC cohort.. PubMed. 156. 59–61. 3 indexed citations
6.
Rasmuson, T., Kjell Grankvist, Jan Jacobsen, & Börje Ljungberg. (2001). Impact of serum basic fibroblast growth factor on prognosis in human renal cell carcinoma. European Journal of Cancer. 37(17). 2199–2203. 23 indexed citations
7.
Werner, Stefan, B.-Å. Bengtsson, Björn Petruson, et al.. (1999). [Prolactin--a hormone with many effects].. PubMed. 96(10). 1171–4. 1 indexed citations
8.
Ljungberg, Börje, Kjell Grankvist, & T. Rasmuson. (1997). Serum interleukin-6 in relation to acute-phase reactants and survival in patients with renal cell carcinoma. European Journal of Cancer. 33(11). 1794–1798. 80 indexed citations
9.
Rasmuson, T., Kjell Grankvist, & Börje Ljungberg. (1997). Soluble ectodomain of c-erbB-2 oncoprotein in relation to tumour stage and grade in human renal cell carcinoma. British Journal of Cancer. 75(11). 1674–1677. 4 indexed citations
10.
Ljungberg, Börje, T. Rasmuson, & Kjell Grankvist. (1992). Erythropoietin in Renai Celi Carcinoma: Evaluation of Its Usefulness as a Tumor Marker. European Urology. 21(2). 160–163. 36 indexed citations
11.
Rasmuson, T., Glenn R. Björk, S.-O. Hietala, Roger Stenling, & Börje Ljungberg. (1991). Excretion of Pseudouridine as an Independent Prognostic Factor in Renal Cell Carcinoma. Acta Oncologica. 30(1). 11–15. 9 indexed citations
12.
Rasmuson, T., Glenn R. Björk, Lena Damber, et al.. (1987). Tumor Markers in Mammary Carcinoma: An evaluation of carcinoembryonic antigen, placental alkaline phosphatase, pseudouridine and CA-50. Acta Oncologica. 26(4). 261–267. 19 indexed citations
13.
Rasmuson, T., et al.. (1985). Pseudouridine: a prognostic marker in non-Hodgkin's lymphomas.. PubMed. 8(1-2). 287–90. 6 indexed citations
14.
Rasmuson, T., A. Jeppsson, & Torgny Stigbrand. (1984). Placental and placental-like alkaline phosphatases in sera from healthy adults and cancer patients.. PubMed. 166. 309–15. 1 indexed citations
15.
Rasmuson, T., Glenn R. Björk, Lena Damber, et al.. (1984). Tumor Markers in Colorectal Carcinoma An Evaluation of Carcinoembryonic Antigen, Tissue Polypeptide Antigen, Placental Alkaline Phosphatase and Pseudouridine. Acta Radiologica Oncology. 23(1). 27–32. 7 indexed citations
16.
Rasmuson, T., Glenn R. Björk, Lena Damber, et al.. (1983). Tumor Markers in Bronchogenic Carcinoma: An Evaluation of Carcinoembryonic Antigen, Tissue Polypeptide Antigen, Placental Alkaline Phosphatase and Pseudouridine. Acta Radiologica Oncology. 22(3). 209–214. 27 indexed citations
17.
18.
Rasmuson, T., et al.. (1983). Pseudouridine: a modified nucleoside as biological marker in malignant lymphomas.. PubMed. 6(1-2). 293–6. 12 indexed citations
19.
20.
Adolfsson, Lars, Nils‐Holger Areskog, & T. Rasmuson. (1971). Effects of alprenolol and sorbidnitrate during exercise in patients with coronary insufficiency. European Journal of Clinical Pharmacology. 3(2). 68–73. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bence Kiss Breakdown of academic impact, for papers by Ilona Moßbrugger Breakdown of academic impact, for papers by Satoshi Shiojima Breakdown of academic impact, for papers by Tetsuhiro Tsuruma Breakdown of academic impact, for papers by Deric D. Schoof Breakdown of academic impact, for papers by H Okazaki Breakdown of academic impact, for papers by Laurie Burdett Breakdown of academic impact, for papers by Melanie Grusdat Breakdown of academic impact, for papers by Yoko Ino Breakdown of academic impact, for papers by Anna Aspesi
Rankless by CCL
2026